Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

In late January 2026, Webull Financial LLC highlighted its expanding partnership with CFTC-regulated Kalshi, offering users sports and Big Game prediction markets with $0 commission on select event ...

WeBull Financial was hit with a consumer class action on Dec. 12 in New York Southern District Court. The suit, brought by Simoni Consumers Class Action Law Offices on behalf of customers who ...

NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Webull, a leading digital investment platform, today announced the expansion of its crypto futures offering with Coinbase (COIN) Derivatives, LLC (Coinbase ...

MIAMI--(BUSINESS WIRE)--ShiftPixy, Inc. (Nasdaq: PIXY) (“ShiftPixy” or the “Company”), a Florida-based national human capital provisioning enterprise which designs, manages, and sells access to a ...

Webull enhances its advisory platform by integrating BlackRock's model portfolio capabilities, expanding investment options to better serve a broad range of investment needs. Webull users now have ...

Wall Street watchdog fines Webull for options customer approval violations The Financial Industry Regulatory Authority on Thursday said it fined retail brokerage Webull Financial $3 million for ...

Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with innovative tools and cutting-edge technology. With low-cost trading on a wide range of ...

PM EST OCALA, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today that it will participate in the Corporate Connect Webinar Series hosted ...

HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in the Corporate Connect Webinar Series ...

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it will ...